Status:

UNKNOWN

Misoprostol For Nulliparous Women Before Hysteroscopy

Lead Sponsor:

Wenzhou Medical University

Conditions:

Cervical Ripening

Eligibility:

FEMALE

16-40 years

Phase:

PHASE3

Brief Summary

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysterosco...

Detailed Description

There is no consensus on the effect of misoprostol on cervical ripening for nulliparous women. The aim of the study is to compare the impact of 400-microgram self-administered vaginal versus self-admi...

Eligibility Criteria

Inclusion

  • nulliparous women who are referred to outpatient hysteroscopy and who have given informed consent will be eligible for study recruitment.

Exclusion

  • women with a known allergy to misoprostol.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2011

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT01156948

Start Date

May 1 2008

End Date

December 1 2011

Last Update

July 8 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the 1st Affiliated Hospital of Wenzhou Medical College

Wenzhou, Zhejiang, China, 325000